The constrained prescription, interchangeability and substitution of biosimilars

Nat Biotechnol. 2015 Jul;33(7):688-9. doi: 10.1038/nbt.3272.
No abstract available

Publication types

  • Letter

MeSH terms

  • Biosimilar Pharmaceuticals*
  • Drug Industry
  • Drug Prescriptions*
  • Drug Substitution*
  • Europe
  • Humans
  • United States
  • United States Food and Drug Administration

Substances

  • Biosimilar Pharmaceuticals